Low Dopamine Function in Attention Deficit/Hyperactivity Disorder: Should Genotyping Signify Early Diagnosis in Children?

References

• . Greenhill LL, Posner K, Vaughan BS, Kratochvil CJ. Attention deficit hyperactivity disorder in preschool children. Child Adolesc Psychiatr Clin N Am. 2008;17(2):347–366, ix
   PubMedGoogle Scholar
• . Setlik J, Bond GR, Ho M. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications. Pediatrics. 2009;124(3):875–880
   PubMed Web of Science ®Google Scholar
• . Archer T, Oscar-Berman M, Blum K. Epigenetics in Developmental Disorder: ADHD and Endophenotypes. J Genet Syndr Gene Ther. 2011;2(104):ii
   Google Scholar
• . Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998;279(14):1100–1107
   PubMed Web of Science ®Google Scholar
• . Huang YS, Tsai MH, Guilleminault C. Pharmacological treatment of ADHD and the short and long term effects on sleep. Curr Pharm Des. 2011;17:1450–1458
   PubMed Web of Science ®Google Scholar
• . Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev. 2000;24(1):7–12
   PubMed Web of Science ®Google Scholar
• . MacDonald SW, Cervenka S, Farde L, Nyberg L, Backman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia. 2009;47(11):2299–2304
   PubMedGoogle Scholar
• . Wild-Wall N, Oades RD, Schmidt-Wessels M, Christiansen H, Falkenstein M. Neural activity associated with executive functions in adolescents with attention-deficit/hyperactivity disorder (ADHD). Int J Psychophysiol. 2009;74(1):19–27
   PubMedGoogle Scholar
• . Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9(1):77–97
   PubMed Web of Science ®Google Scholar
• . Mannuzza S, Klein RG, Moulton JL 3rd. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res. 2008;160(3):237–246
   PubMed Web of Science ®Google Scholar
• . American Association of Pediatrics (AAP). Caring for Children With ADHD: A Resource Toolkit for Clinicians, 2nd ed [CD-ROM]. Elk Grove Village, IL: American Academy of Pediatrics, 2011
   Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV, Fourth Edition (DSM-IV-TR). Arlington, VA: American Psychiatric Association; 2000
   Google Scholar
• . Dang MT, Warrington D, Tung T, Baker D, Pan RJ. A school-based approach to early identification and management of students with ADHD. J Sch Nurs. 2007;23(1):2–12
   PubMedGoogle Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders V, Fifth Edition. Arlington, VA; 2013
   Google Scholar
• . Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol. 2005;34(3):449–476
   PubMed Web of Science ®Google Scholar
• . Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114(5):e541–e547
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Issues in the diagnosis of attention-deficit/hyperactivity disorder in children. Brain Dev. 2003;25(2):77–83
   PubMed Web of Science ®Google Scholar
• . Karama S, Grizenko N, Sonuga-Barke E, . Dopamine transporter 3′UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry. 2008;8:45
   PubMed Web of Science ®Google Scholar
• . King JA, Barkley RA, Barrett S. Attention-deficit hyperactivity disorder and the stress response. Biol Psychiatry. 1998;44(1):72–74
   PubMedGoogle Scholar
• . Blum K, Chen ALC, Chen TJH, . Putative targeting of dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex Variant (KB220): Clinical trial showing anti-anxiety effects. Gene Therapy and Molecular Biology. 2009;13:214–230
   Google Scholar
• . Biederman J, Petty CR, Fried R, . Utility of an abbreviated questionnaire to identify individuals with ADHD at risk for functional impairments. J Psychiatr Res. 2008;42:304–310
   PubMedGoogle Scholar
• . Bartell SS, Solanto MV. Usefulness of the Rorschach inkblot test in assessment of attention deficit hyperactivity disorder. Percept Mot Skills. 1995;80(2):531–541
   PubMedGoogle Scholar
• . Re AM, Cornoldi C. Two new rating scales for assessment of ADHD symptoms in italian preschool children: a comparison between parent and teacher ratings. J Atten Disord. 2009;12(6):532–539
   PubMed Web of Science ®Google Scholar
• . Escobar R, Hervas A, Soutullo C, Mardomingo MJ, Urunuela A, Gilaberte I. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children]. Actas Esp Psiquiatr. 2008;36(5):285–294
   PubMed Web of Science ®Google Scholar
• . Edwards MC, Gardner ES, Chelonis JJ, Schulz EG, Flake RA, Diaz PF. Estimates of the validity and utility of the Conners' Continuous Performance Test in the assessment of inattentive and/or hyperactive-impulsive behaviors in children. J Abnorm Child Psychol. 2007;35(3):393–404
   PubMed Web of Science ®Google Scholar
• . Schatz AM, Ballantyne AO, Trauner DA. Sensitivity and specificity of a computerized test of attention in the diagnosis of Attention-Deficit/Hyperactivity Disorder. Assessment. 2001;8(4):357–365
   PubMedGoogle Scholar
• . Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007;11(2):106–113
   PubMedGoogle Scholar
• . Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857–864
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Adler LA, Adams J, . ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31
   PubMed Web of Science ®Google Scholar
• . Jensen PS, Kettle L, Roper MT, . Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry. 1999;38(7):797–804
   PubMedGoogle Scholar
• . Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Ann N Y Acad Sci. 2001;931:251–270
   PubMed Web of Science ®Google Scholar
• . Geller I, Hartmann R, Blum K. Effects of nicotine, nicotine mono-methiodide, lobeline, chlordiazepoxide, meprobamate and caffeine on a discrimination task in laboratory rats. Psychopharmacologia. 1971;20:355–65
   PubMedGoogle Scholar
• . Blum K, Chen AL, Braverman ER, . Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat. 2008;4(5):893–918
   PubMedGoogle Scholar
• . Lahey BB, Pelham WE, Loney J, Lee SS, Willcutt E. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry. 2005;62(8):896–902
   PubMed Web of Science ®Google Scholar
• . Lahey BB, Pelham WE, Chronis A, . Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. J Child Psychol Psychiatry. 2006;47(5):472–479
   PubMedGoogle Scholar
• . Foreman DM, Ford T. Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England. Child Adolesc Psychiatry Ment Health. 2008;2(1):32
   PubMedGoogle Scholar
• . Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325–341
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44(10):951–958
   PubMed Web of Science ®Google Scholar
• . Insel T. Directors Blog: Transforming Diagnosis NIMH Director's Position on DSM5, April 29, 2013. http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml. Accessed June 5, 2013
   Google Scholar
• . Viggiano D, Vallone D, Sadile A. Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. Neural Plast. 2004;11(1–2):97–114
   PubMedGoogle Scholar
• . Sagvolden T, Pettersen MB, Larsen MC. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav. 1993;54(6):1047–1055
   PubMedGoogle Scholar
• . Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev. 1985;9(3):469–477
   PubMed Web of Science ®Google Scholar
• . Zimmer L. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD. Neuropharmacology. 2009;57(7–8):601–607
   PubMed Web of Science ®Google Scholar
• . Leo D, Sorrentino E, Volpicelli F, . Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci Biobehav Rev. 2003;27(7):661–669
   PubMedGoogle Scholar
• . Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry. 2004;9(7):718–726
   PubMed Web of Science ®Google Scholar
• . Sagvolden T, Dasbanerjee T, Zhang-James Y, Middleton F, Faraone S. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype. Behav Brain Funct. 2008;4:56
   PubMedGoogle Scholar
• . Sutherland KR, Alsop B, McNaughton N, Hyland BI, Tripp G, Wickens JR. Sensitivity to delay of reinforcement in two animal models of attention deficit hyperactivity disorder (ADHD). Behav Brain Res. 2009;205(2):372–376
   PubMedGoogle Scholar
• . Li Q, Lu G, Antonio GE, . The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem Int. 2007;50(6):848–857
   PubMedGoogle Scholar
• . Carey MP, Diewald LM, Esposito FJ, . Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res. 1998;94:173–185
   PubMedGoogle Scholar
• . Yoshimasu K, Barbaresi WJ, Colligan RC, . Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry. 2012;53:1036–1043
   PubMed Web of Science ®Google Scholar
• . Field LL, Shumansky K, Ryan J, Truong D, Swiergala E, Kaplan BJ. Dense-map genome scan for dyslexia supports loci at 4q13, 16p12, 17q22; suggests novel locus at 7q36. Genes Brain Behav. 2013;12(1):56–69
   PubMedGoogle Scholar
• . Ponce G, Jimenez-Arriero MA, Rubio G, . The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry. 2003;18:356–360
   PubMed Web of Science ®Google Scholar
• . Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet. 1998;81(3):257–267
   PubMed Web of Science ®Google Scholar
• . Han DH, Yoon SJ, Sung YH, . A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr Psychiatry. 2008;49(4):387–392
   PubMedGoogle Scholar
• . Ratsma JE, van der Stelt O, Schoffelmeer AN, Westerveld A, Boudewijn Gunning W. P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol Clin Exp Res. 2001;25(7):960–967
   PubMedGoogle Scholar
• . Hill SY, Zezza N, Wipprecht G, Xu J, Neiswanger K. Linkage studies of D2 and D4 receptor genes and alcoholism. Am J Med Genet. 1999;88(6):676–685
   PubMedGoogle Scholar
• . Comings DE, Chen TJ, Blum K, Mengucci JF, Blum SH, Meshkin B. Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder. (ADHD): dispelling myths. Theor Biol Med Model 2005;2:50
   PubMedGoogle Scholar
• . Comings DE, Comings BG, Muhleman D, . The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 1991;266(13):1793–1800
   PubMed Web of Science ®Google Scholar
• . Comings DE, Wu S, Chiu C, . Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes–DRD2, D beta H, and DAT1. Am J Med Genet. 1996;67(3):264–288
   PubMed Web of Science ®Google Scholar
• . Sery O, Drtilkova I, Theiner P, . Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett. 2006;27(1–2):236–240
   PubMed Web of Science ®Google Scholar
• . Kopeckova M, Paclt I, Petrasek J, Pacltova D, Malikova M, Zagatova V. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6–10 age. Neuro Endocrinol Lett. 2008;29(2):246–251
   PubMedGoogle Scholar
• . Ballon N, Leroy S, Roy C, . Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3′ UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):1034–1041
   PubMedGoogle Scholar
• . McClernon FJ, Fuemmeler BF, Kollins SH, Kail ME, Ashley-Koch AE. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine Tob Res. 2008;10(1):117–127
   PubMedGoogle Scholar
• . Rowe DC, Van den Oord EJ, Stever C, . The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry. 1999;4(6):580–586
   PubMedGoogle Scholar
• . Huang YS, Lin SK, Wu YY, Chao CC, Chen CK. A family-based association study of attention-deficit hyperactivity disorder and dopamine D2 receptor TaqI A alleles. Chang Gung Med J. 2003;26(12):897–903
   PubMedGoogle Scholar
• . Todd RD, Lobos EA. Mutation screening of the dopamine D2 receptor gene in attention-deficit hyperactivity disorder subtypes: preliminary report of a research strategy. Am J Med Genet. 2002;114(1):34–41
   PubMedGoogle Scholar
• . Nyman ES, Ogdie MN, Loukola A, . ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2. J Am Acad Child Adolesc Psychiatry. 2007;46(12):1614–1621
   PubMed Web of Science ®Google Scholar
• . Drtilkova I, Sery O, Theiner P, . Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett. 2008;29(3):320–327
   PubMedGoogle Scholar
• . Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):109–125
   PubMedGoogle Scholar
• . Alsobrook JP 2nd, Pauls DL. Molecular approaches to child psychopathology. Hum Biol. 1998;70:413–432
   PubMed Web of Science ®Google Scholar
• . Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 1995;5(3):121–141
   PubMedGoogle Scholar
• . Cook EH Jr, Stein MA, Krasowski MD, . Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56(4):993–998
   PubMed Web of Science ®Google Scholar
• . Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 1997;2(4):311–313
   PubMedGoogle Scholar
• . Vandenbergh DJ, Thompson MD, Cook EH, . Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry. 2000;5(3):283–292
   PubMedGoogle Scholar
• . Barr CL, Xu C, Kroft J, . Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001;49(4):333–339
   PubMed Web of Science ®Google Scholar
• . Lee SS, Lahey BB, Waldman I, . Association of dopamine transporter genotype with disruptive behavior disorders in an eight-year longitudinal study of children and adolescents. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(3):310–317
   PubMedGoogle Scholar
• . Barkley RA, Smith KM, Fischer M, Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(5):487–498
   PubMedGoogle Scholar
• . Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007;61(12):1320–1328
   PubMedGoogle Scholar
• . Swanson JM, Flodman P, Kennedy J, . Dopamine genes and ADHD. Neurosci Biobehav Rev. 2000;24(1):21–25
   PubMed Web of Science ®Google Scholar
• . Brookes K, Xu X, Chen W, . The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11(10):934–953
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Perlis RH, Doyle AE, . Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323
   PubMed Web of Science ®Google Scholar
• . Szobot C, Roman T, Cunha R, Acton P, Hutz M, Rohde LA. Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):53–58
   PubMedGoogle Scholar
• . Mill J, Caspi A, Williams BS, . Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatry. 2006;63(4):462–469
   PubMedGoogle Scholar
• . Stevens SE, Kumsta R, Kreppner JM, Brookes KJ, Rutter M, Sonuga-Barke EJ. Dopamine transporter gene polymorphism moderates the effects of severe deprivation on ADHD symptoms: developmental continuities in gene-environment interplay. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(6):753–761
   PubMed Web of Science ®Google Scholar
• . Wohl M, Purper-Ouakil D, Mouren MC, Ades J, Gorwood P. [Meta-analysis of candidate genes in attention-deficit hyperactivity disorder]. Encephale. 2005;31(4 Pt 1):437–447
   PubMedGoogle Scholar
• . Aguirre-Samudio AJ, Nicolini H. [DRD4 polymorphism and the association with mental disorders]. Rev Invest Clin. 2005;57(1):65–75
   PubMedGoogle Scholar
• . LaHoste GJ, Swanson JM, Wigal SB, . Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996;1:121–124
   PubMed Web of Science ®Google Scholar
• . Haile CN, Kosten TR, Kosten TA. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse. 2009;35(3):161–177
   PubMed Web of Science ®Google Scholar
• . Langley K, Fowler TA, Grady DL, . Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2009;18(1):26–32
   PubMedGoogle Scholar
• . Bakermans-Kranenburg MJ, van Ijzendoorn MH. Gene-environment interaction of the dopamine D4 receptor (DRD4) and observed maternal insensitivity predicting externalizing behavior in preschoolers. Dev Psychobiol. 2006;48(5):406–409
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1052–1057
   PubMed Web of Science ®Google Scholar
• . Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009;126(1):51–90
   PubMed Web of Science ®Google Scholar
• . Althaus M, Groen Y, Wijers AA, . Differential effects of 5-HT-TLPR and DRD2/ANKK1 polymorphisms on electrocortical measures of error and feedback processing in children. Clin Neurophysiol. 2009;120(1):93–107
   PubMedGoogle Scholar
• . Rush RA, Geffen LB. Dopamine beta-hydroxylase in health and disease. Crit Rev Clin Lab Sci. 1980;12(3):241–277
   PubMedGoogle Scholar
• . Egeland JA. A genetic study of manic-depressive disorder among the old order Amish of Pennsylvania. Pharmacopsychiatry. 1988;21:74–75
   PubMedGoogle Scholar
• . Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL. Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry. 1982;139(3):307–311
   PubMedGoogle Scholar
• . Hess C, Reif A, Strobel A, . A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm. 2009;116(2):121–130
   PubMed Web of Science ®Google Scholar
• . Molinoff PB, Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem. 1971;40:465–500
   PubMed Web of Science ®Google Scholar
• . Stein MB, Fallin MD, Schork NJ, Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology. 2005;30(11):2092–2102
   PubMed Web of Science ®Google Scholar
• . Bruder GE, Keilp JG, Xu H, . Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry. 2005;58:901–907
   PubMed Web of Science ®Google Scholar
• . Caspi A, Moffitt TE, Cannon M, . Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117–1127
   PubMed Web of Science ®Google Scholar
• . Qian QJ, Liu J, Wang YF, Yang L, Guan LL, Faraone SV. Attention Deficit Hyperactivity Disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. Behav Brain Funct. 2009;5:8
   PubMedGoogle Scholar
• . Murooka Y, Harada T. Regulation of derepressed synthesis of arylsulfatase by tyramine oxidase in Salmonella typhimurium. J Bacteriol. 1981;145(2):796–802
   PubMedGoogle Scholar
• . Meyer JH, Ginovart N, Boovariwala A, . Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63(11):1209–1216
   PubMed Web of Science ®Google Scholar
• . Domino EF, Khanna SS. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients. Am J Psychiatry. 1976;133(3):323–326
   PubMedGoogle Scholar
• . Fowler JS, Volkow ND, Wang GJ, . Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis. 1998;17(1):23–34
   PubMed Web of Science ®Google Scholar
• . Li J, Kang C, Zhang H, . Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):430–433
   PubMed Web of Science ®Google Scholar
• . Caspi A, McClay J, Moffitt TE, . Role of genotype in the cycle of violence in maltreated children. Science. 2002;297(5582):851–854
   PubMed Web of Science ®Google Scholar
• . Chen TJH, Blum K, Mathews D, . Preliminary association of both the dopamine D2 receptor (DRD2) [Taq1 A1 allele] and the dopamine transporter (DAT1) [480 bp allele] genes with pathological aggressive behavior, a clinical subtype of Reward Deficiency Syndrome (RDS) in adolescents. Gene Therapy and Molecular Biology. 2007;11:93–112
   Google Scholar
• . Ronai Z, Szekely A, Nemoda Z, . Association between novelty seeking and the −521 C/T polymorphism in the promoter region of the DRD4 gene. Mol Psychiatry. 2001;6(1):35–38
   PubMedGoogle Scholar
• . Edinur HA, Dunn PP, Hammond L, . Using HLA loci to inform ancestry and health in Polynesian and Maori populations. Tissue Antigens. 2012;80(6):509–522
   PubMedGoogle Scholar
• . Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase: A gene promoter. Hum Genet. 1998;103(3):273–279
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen TJ, Meshkin B, . Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis. Med Hypotheses. 2007;69(5):1054–1060
   PubMed Web of Science ®Google Scholar
• . Xu X, Brookes K, Chen CK, Huang YS, Wu YY, Asherson P. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry. 2007;7:10–22
   PubMed Web of Science ®Google Scholar
• . Domschke K, Sheehan K, Lowe N, . Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):110–114
   PubMed Web of Science ®Google Scholar
• . Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO. ADHD and Disruptive Behavior scores – associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry. 2008;8:28
   PubMed Web of Science ®Google Scholar
• . Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 1990 Apr 18;263(15):2055–2060
   PubMed Web of Science ®Google Scholar
• . Hill SY. Alternative strategies for uncovering genes contributing to alcoholism risk: unpredictable findings in a genetic wonderland. Alcohol 1998;16:53–9
   PubMed Web of Science ®Google Scholar
• . Blum K, Fornari F, Downs BW, . Genetic Addiction Risk Score (GARS): Testing for polygenetic predisposition and risk to Reward Deficiency Syndrome (RDS). In King C, ed. Gene Therapy Applications. Croatia: Intech Open Access; 2011: Chapter 19;327–362
   Google Scholar
• . Biederman J, Petty CR, Monuteaux MC, . Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study. J Child Psychol Psychiatry. 2009;50(3):352–358
   PubMedGoogle Scholar
• . Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Croft RJ. EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder. Clin Neurophysiol. 2002;113(8):1191–1198
   PubMedGoogle Scholar
• . King S, Griffin S, Hodges Z, . A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol. 2006;10(23):iii–iv, xiii–146
   Google Scholar
• . Grizenko N, Bhat M, Schwartz G, Ter-Stepanian M, Joober R. Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry NeuroSci. 2006;31(1):46–51
   PubMed Web of Science ®Google Scholar
• . Stein MA, Waldman ID, Sarampote CS, . Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology. 2005;30(7):1374–1382
   PubMed Web of Science ®Google Scholar
• . Kolch M, Allroggen M, Fegert JM. [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem]. Nervenarzt. 2009;80(70):789–796
   PubMedGoogle Scholar
• . Ruocco LA, de Souza Silva MA, Topic B, Mattern C, Huston JP, Sadile AG. Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD. Eur Neuropsychopharmacol. 2009;19(10):693–701
   PubMedGoogle Scholar
• . Blum K, Chen ACL, Oscar-Berman M, . Generational association studies of dopaminergic genes in Reward Deficiency Syndrome (RDS) subjects: Selecting appropriate phenotypes for reward dependence behaviors. Int J Environ Res Public Health. 2011;8(12):4425–4459
   PubMedGoogle Scholar
• . Arnsten AF. The use of α-2 A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2010;10(10):1595–1605
   PubMed Web of Science ®Google Scholar
• . Levy F. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC. Behav Brain Funct. 2008;4:12
   PubMed Web of Science ®Google Scholar
• . Downs BW, Chen AL, Chen TJ, . Nutrigenomic targeting of carbohydrate craving behavior: can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map? Med Hypotheses. 2009;73(3):427–434
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen AL, Chen TJ, . Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model. 2008;5:24
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen AL, Chen TJ, . LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Adv Ther. 2008;25:894–913
   PubMed Web of Science ®Google Scholar
• . Chen TJ, Blum K, Waite RL, . Gene\Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome. Adv Ther. 2007;24(2):402–414
   PubMedGoogle Scholar
• . Blum K, Chen TJ, Meshkin B, . Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant. Adv Ther. 2006;23(6):1040–1051
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen TJ, Meshkin B, . Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS). Med Hypotheses. 2007;68(4):844–852
   PubMed Web of Science ®Google Scholar
• . Chen TJ, Blum K, Mathews D, . Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of “super normal controls” in psychiatricgenetic research of complex behavioral disorders. Med Hypotheses. 2005;65(4):703–707
   PubMed Web of Science ®Google Scholar
• . Chen TJ, Blum K, Payte JT, . Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy. Med Hypotheses. 2004;63(3):538–548
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen TJH, Williams L, . A short term pilot open label study of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics. Gene Therapy and Molecular Biology. 2008;12:371–382
   Google Scholar
• . Brown RJ, Blum K, Trachtenberg MC. Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders. J Psychoactive Drugs. 1990;22(2):173–187
   PubMed Web of Science ®Google Scholar
• . Blum K, Trachtenberg MC, Elliott CE, . Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE. Alcohol. 1988;5:481–493
   PubMed Web of Science ®Google Scholar
• . Blum K, Trachtenberg MC, Ramsay JC. Improvement of inpatient treatment of the alcoholic as a function of neurotransmitter restoration: a pilot study. Int J Addict. 1988;23(9):991–998
   PubMed Web of Science ®Google Scholar
• . Blum K, Trachtenberg MC. Neurogenetic deficits caused by alcoholism: restoration by SAAVE, a neuronutrient intervention adjunct. J Psychoactive Drugs. 1988;20(3):297–313
   PubMed Web of Science ®Google Scholar
• . Trachtenberg MC, Blum K. Improvement of cocaine-induced neuro-modulator deficits by the neuronutrient Tropamine. J Psychoactive Drugs. 1988;20(3):315–331
   PubMed Web of Science ®Google Scholar
• . Blum K, Chen T, Meshkin B, . The PPAR-gamma Pro12 Ala allele polymorphism of the Peroxisome Profiferator-Activated Receptor (gamma) Gene (PPARG2) Is a Risk Factor With a Self-Identified Obese Dutch Population. Gene Therapy and Molecular Biology. 2007;11:37–42
   Google Scholar
• . Chen T, Blum K, Kaats G, . Chromium Picolinate (CrP) a putative anti-obesity nutrient induces changes in body composition as a function of the Taq1 dopamine D2 receptor polymorphisms in a randomized double-blind placebo controlled study. Gene Therapy and Molecular Biology. 2007;11:161–170
   Google Scholar
• . Blum K, Chen TJH, Downs BW, . Synaptamine (SG8839) An Amino-acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS). Trends in Applied Sciences Research. 2007;2(2):132–138
   Google Scholar
• . Chen ALC, Blum K, Chen TJH, . The impact of biomics technology and DNA directed anti-obesity targeting of the brain reward circuitry. Gene Therapy and Molecular Biology. 2008;12:45–68
   Google Scholar
• . Blum K, Chen TJH, Chen ALC, . Dopamine D2 Receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands. Gene Therapy and Molecular Biology. 2008;12:129–140
   Google Scholar
• . Blum K, Trachtenberg MC, Cook DW. Neuronutrient effects on weight loss in carbohydrate bingers: An open clinical trial. Curr Ther Res. 1990;48:217–33
   Web of Science ®Google Scholar
• . Blum K, Allison D, Trachtenberg MC, Williams RW, Loeblich LA. Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30 day inpatient treatment program by the neuronutrient Tropamine. Curr Ther Res. 1988;43:1204–1214
   Web of Science ®Google Scholar
• . Blum K, Giordano J, Borsten J, . Translational research to uncover diagnostic and therapeutic gene targets emerging in a genomic era: From bench to bedside. J Genet Dis and Dis Info. 2012;1:1–3
   Google Scholar
• . Weissman MM. Phenotype definitions: some hidden issues in psychiatry. Am J Med Genet. 2001;105(1):45–47
   PubMedGoogle Scholar
• . Nuffield Council on Bioethics. Genetic Screening Ethical Issues. London: Nuffield Council on Bioethics; 1993. http://www.nuffieldbioethics.org/sites/default/files/Genetic_screening_report.pdf. Accessed September 10, 2013
   Google Scholar
• . Kluchin RM. Fit to Be Tied: Sterilization and Reproductive Rights in America, 1950–1980. New Brunswick, NJ: Rutgers University Press; 2009:17–20
   Google Scholar
• . Tursz A. [Mental disorders in children: the value of epidemiology]. Arch Pediatr. 2001;8:191–203
   PubMedGoogle Scholar
• . Biederman J, Monuteaux MC, Mick E, . Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry. 2006;59(3):258–264
   PubMed Web of Science ®Google Scholar
• . Appelbaum PS. Ethical issues in psychiatric genetics. J Psychiatr Pract. 2004;10(6):343–351
   PubMedGoogle Scholar
• . SA HealthInfo. du Toit D. 3. Ethics in genetic research and practice. 2013. http://www.sahealthinfo.org/ethics/book2genetesting.htm. Accessed June 11, 2013
   Google Scholar
• . Tullis LM, Frost-Pineda K, DuPont R, Gold MS. Marijuana and tobacco: A major connection. J Addict Dis. 2003;22(3):51–62
   PubMed Web of Science ®Google Scholar
• . Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2006;163(2):2059–2063
   PubMedGoogle Scholar
• . Graham NA, DuPont RL, Gold MS. Symptoms of ADHD or marijuana use? Am J Psychiatry. 2007;164(6):973–974
   PubMedGoogle Scholar
• . Volkow ND, Wang GJ, Kollins SH, . Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009;302(10):1084–1091
   PubMed Web of Science ®Google Scholar
• . Volkow ND, Wang GJ, Newcorn J, . Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007;64(8):932–940
   PubMed Web of Science ®Google Scholar
• . Dalley JW, Fryer TD, Brichard L, . Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315(5816):1267–1270
   PubMed Web of Science ®Google Scholar
• . Davis C, Patte K, Levitan RD, . A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder. J Psychiatr Res. 2009;43(7):687–696
   PubMedGoogle Scholar
• . vetlov SI, Kobeissy FH, Gold MS. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. J Addict Dis. 2007;26(4):1–6
   Google Scholar
• . Gray L, Park JJ, Msall ME. Children and adolescents with ADHD: Risk and protective factors for substance abuse and addictions. In: Miller NS, Gold MS, eds. Addictive Disorders in Medical Populations. Hoboken, NJ: Wiley Blackwell; 2010:455–466
   Google Scholar
• . Paclt I, Drtilkova I, Kopeckova M, Theiner P, Sery O, Cermakova N. The association between TaqI A polymorphism of ANKK1 (DRD2) gene and ADHD in the Czech boys aged between 6 and 13 years. Neuro Endocrinol Lett. 2010;31(1):131–136
   PubMedGoogle Scholar
• . Esposito-Smythers C, Spirito A, Rizzo C, McGeary JE, Knopik VS. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav. 2009;93(3):306–312
   PubMed Web of Science ®Google Scholar
• . Ries RK, Fiellin DA, Miller SC, Saitz R, eds. Principles of Addiction Medicine, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009
   Google Scholar
• . Reef J, van Meurs I, Verhulst FC, van der Ende J. Children's problems predict adults' DSM-IV disorders across 24 years. J Am Acad Child Adolesc Psychiatry. 2010;49(11):1117–1124
   PubMed Web of Science ®Google Scholar
• . Biederman J, Petty CR, Clarke A, Lomedico A, Faraone SV. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res. 2011;45(2):150–155
   PubMed Web of Science ®Google Scholar
• . Johnson RJ, Gold MS, Johnson DR, . Attention-deficit/hyperactivity disorder: Is it time to reappraise the role of sugar consumption? Postgrad Med. 2011;123(5):39–49
   PubMed Web of Science ®Google Scholar
• . Fletcher J, Wolfe B. Long-term consequences of childhood ADHD on criminal activities. J Ment Health Policy Econ. 2009;12(3):119–138
   PubMed Web of Science ®Google Scholar
• . DeFrance JF, Hymel C, Trachtenberg MC, . Enhancement of attention processing by Kantroll in healthy humans: a pilot study. Clin Electroencephalogr. 1997;28(2):68–75
   PubMedGoogle Scholar